InternationalUSRemember you can easily switch between MIP US and MIP International at any time

No expert needed to hear Novartis patent appeal

Peter Ollier, London


An Indian court has decided on the composition of the board that will hear the appeal by Swiss drug maker Novartis against the rejection of its patent application for the blockbuster anti-cancer drug Glivec

On Monday the Chennai High Court accepted the government’s proposal that the Intellectual Property Appellate Board (IPAB) hear the case without a technical member. This leaves only the chairman, Justice MHS Ansari and vice-chairman, ZS Negi.

The court...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

More from the Managing IP blog


null null null

null null null


November / December 2019

IP law: are the pressures taking their toll?

Following World Mental Health Day, Max Walters seeks the views of in-house professionals on whether they struggle with workplace pressures, and asks how to improve wellbeing



Most read articles

Supplements